Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC).
about
T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and OpportunitiesAn immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers.Tumor-infiltrating lymphocytes and breast cancer: Beyond the prognostic and predictive utility.No effect of tumor-infiltrating lymphocytes (TILs) on prognosis in patients with early triple-negative breast cancer: Validation of recommendations by the International TILs Working Group 2014.Identification of candidate genes associated with triple negative breast cancer.Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune TherapyCharacterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast.Single-cell heterogeneity in ductal carcinoma in situ of breast.Depletion of tumor-associated macrophages switches the epigenetic profile of pancreatic cancer infiltrating T cells and restores their anti-tumor phenotype.Her2-neu score as a prognostic factor for outcome in patients with triple-negative breast cancer.Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors.Trial watch: DNA-based vaccines for oncological indicationsPrecision medicine based on tumorigenic signaling pathways for triple-negative breast cancer
P2860
Q28074619-9B5D0262-92DB-4DE1-A236-B322D523E7B1Q37470361-102FF275-DBCD-4A0A-B624-2DD1FD358A30Q38734804-7E25CFC7-D062-4393-AFDD-69B64F32D680Q40764127-BDB0F20F-51CD-4A4C-B9D8-EB7B4DFB1B9BQ41659323-939A5EEF-377D-44C0-9AD9-E14AD9A7A8DDQ42672834-AE3389BB-AB5B-4940-AD07-A11B88621B28Q44982655-5FEB14F6-06B6-49C3-91DA-FB4824B3B186Q47392563-D514723B-66E0-4779-AFA7-63935C329651Q50545391-A0339ED7-1EB8-4C06-8471-E848DBB0E5D0Q54110141-1FF2F008-AD62-4A3C-995D-33CAEA725C8EQ55049458-01D66BD1-7C2E-47F8-8FFB-B16F2DA1DAFBQ56893452-4DF2BDA8-92BE-4678-8B5D-BB81BBE679A5Q57105411-B9A9F26E-70B9-41E7-94D8-1767D42B2FB2
P2860
Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Tumor infiltrating lymphocytes ...... negative breast cancer (TNBC).
@ast
Tumor infiltrating lymphocytes ...... negative breast cancer (TNBC).
@en
type
label
Tumor infiltrating lymphocytes ...... negative breast cancer (TNBC).
@ast
Tumor infiltrating lymphocytes ...... negative breast cancer (TNBC).
@en
prefLabel
Tumor infiltrating lymphocytes ...... negative breast cancer (TNBC).
@ast
Tumor infiltrating lymphocytes ...... negative breast cancer (TNBC).
@en
P2093
P2860
P50
P1433
P1476
Tumor infiltrating lymphocytes ...... negative breast cancer (TNBC).
@en
P2093
Joseph A Sparano
Lori J Goldstein
Sunil S Badve
P2860
P304
P356
10.4161/2162402X.2014.985930
P577
2015-07-27T00:00:00Z